Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab ® (Abciximab) in Acute MI Patients
Condition: Acute Myocardial Infarction Interventions: Biological: Abciximab; Biological: Placebo Sponsor: ISU Abxis Co., Ltd. Active, not recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2016 Category: Research Source Type: clinical trials
Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Conditions: Sickle Cell Disease; Hb-SS Disease With Vasoocclusive Pain; Hemoglobin SS Disease With Vasoocclusive Crisis; Other Sickle Cell Disease With Vaso-Occlusive Pain; Hemoglobin SS Disease With CrisisInterventions: Drug: Abciximab; Drug: Placebo; Other: Intravenous hydration; Drug: Ibuprofen; Drug: Parenteral narcotic; Other: Incentive spirometry; Other: Supplemental oxygenSponsors: St. Louis University; Janssen Services, LLCWithdrawn - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2013 Category: Research Source Type: clinical trials